The benchmark indices on Thursday settled the holiday-truncated week lower after index heavyweight Infosys’ revenue guidance and plan to distribute cash to shareholders fell short of expectations, raising concerns at the start of the March quarter earnings.
The geopolitical worries, after the United States launched cruise missiles against an air base in Syria last week and fears of a new weapons test by North Korea, also contributed to the losses.
Investors also took cues from the index of industrial production (IIP) data, which contracted in February and consumer price index (CPI)-based inflation data, which edged up in March.
The S&P BSE Sensex settled at 29,461, down 182 points, while the broader Nifty50 ended at 9,150, down 53 points. For the week, the Sensex shed 245 points or 0.8%, while the Nifty slipped 47 points or 0.5%.
Sensex falls 156 points on Friday to end near 5-month low; Smallcaps and Pharma stocks sink
Benchmark indices ended lower for fifth straight trading sessions dragged down by selling pressure in pharma shares while weak global cues also dampened investor sentiment. Further, consistent selling by foreign portfolio investors along with growing uncertainty over Hillary Clinton’s victory in the US Presidential election also weighed on market sentiment.
The S&P BSE Sensex ended down 156 points to settle at 27,274 and the Nifty50 settled 51 points lower at 8,434. Sensex touched its lowest level since July 8, 2016 in intra-day trade whereas the Nifty dropped to its lowest level since July 11, 2016.
The broader markets underperformed the benchmark indices significantly- BSE Midcap and Smallcap indices fell between 1%-2.5%. Market breadth on the BSE ended lower with 200 declines and 500 advances.
Does StockArchitect have anything else to offer?
During the past two weeks we highlighted some posts where investors could potentially have made money. But is that the sole purpose of StockArchitect? A resounding NO!!! We believe we offer a lot more than just that.
We also offer views of leading analysts. We have pulled some posts from the past week which inform you of what experts think. Our only purpose is to help investors make informed investment decisions. After all it is your hard earned money.